there is a school of thought that suggests that Erbitux would be a good choice for an HPV +ve tumour because it DOESN'T over-express EGFR. Over-expression of EGFR is associated with poor outcome on its own.

I have posted on this in the medications and treatments section on the post "Erbitux and HPV don't play well together" as the points to be made were more academic than supportive of individuals with needs relating to their own situation.

Karen